Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › SGC stimulators in combination with additional treatment for the therapy of cystic fibrosis

SGC stimulators in combination with additional treatment for the therapy of cystic fibrosis

US Patent 10265314 · Granted Apr 23, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination 2025
Stimulators and/or activators of soluble guanylate cyclase (sGC) in combination 2025
Substituted pyrazolo piperidine carboxylic acids2025
Diazabicyclic substituted imidazopyrimidines and their use for the treatment of 2024
Treatment of cardiopulmonary disorders2024
Substituted 5-fluoro-1H-pyrazolopyridines and their use2024
Substituted 5-fluoro-1H-pyrazolopyridines and their use2024
Substituted S-alaninate derivatives2024
Combination containing sGC stimulators and mineralocorticoid receptor antagonist2023
Method of identifying a subgroup of patients suffering from dcSSc which benefits2022
Use of non-steroidal mineralocorticoid receptor antagonists alone or in combinat2022
Substituted 5-fluoro-1H-pyrazolopyridines and their use2022